urinary incontinence
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged >=18 years; 2. Patients receiving AUS implantation for true incontinence/moderate to severe stress incontinence and other diseases; 3. After enrollment, they agreed not to arbitrarily increase or decrease the related drugs affecting lower urinary tract symptoms and pelvic function during the trial; 4. Participate in clinical trials voluntarily and can sign informed consent; 5. Able to communicate well with researchers and willing to comply with the whole experiment requirements.
Exclusion criteria
Exclusion criteria: 1. Absence of case items, especially intraoperative urethral barograph examination; 2. Abnormal anatomical structure of urethra or bladder neck; 3. Abnormal bladder volume and unstable contraction; 4. Mental illness can not work with a doctor; 5. The presence of non-urinary malignancies and other concomitant diseases that seriously affect health; 6. Pregnant and lactating patients; 7. Other conditions that the researcher considers inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum urethral pressure;Maximum urethral closure pressure;Number of urine pads used;Occurrence of complications; | — |
Countries
China
Contacts
Beijing Hospital